Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulants and Blood Loss in Total Hip Arthroplasty
NCT02085824Unknown
- Sponsor
- Centrum Medyczne Kształcenia Podyplomowego
- Start
- Jul 2012
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in venous thromboembolism (VTE) comparing Enoxaparin, Rivaroxaban and Dabigatran (3 arms). Primary endpoint: Total blood loss by the 3rd postoperative day. Status: unknown.
02
Drugs
enoxaparinrivaroxabandabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02085824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085824.